Increased cytokine production in mononuclear cells of healthy elderly people. 1993

U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
Institute of Internal Medicine, University of Padua, Italy.

The production of cytokines during aging, except interleukin (IL)-2, has been neglected in humans. We measured the in vitro production of IL-6, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma and IL-1 beta by peripheral mononuclear cells from selected healthy young (mean age 26.8 years) and aged (mean age 80.2 years) subjects. Significant increases of IL-6, TNF-alpha and IL-1 beta levels were found in mitogen-stimulated cultures from aged donors, occurring at 24 to 72 h after stimulation. No significant differences were observed for IFN-gamma production. Proliferative capability of cells stimulated with PHA was not impaired in aged subjects. Since the amounts of all cytokines studied were similar in unstimulated cultures from young and aged subjects, and also serum levels of TNF-alpha did not differ, these data indicate that the cellular machinery for the production of these cytokines is well preserved in aging, and also that cells from old people are able to up-regulate their production in response to appropriate stimuli. The increases in cytokine synthesis were not dependent on changes in the number of monocytes, nor were they related to the significant rise of CD45RO+, and the concomitant decrease of CD45RA+, occurring in both CD4+ and CD8+ lymphocytes from aged subjects. The increased production of pro-inflammatory cytokines by stimulated mononuclear cells of healthy aged subjects may be relevant to several aspects of age-associated pathological events, including atherosclerosis, osteoporosis, fibrosis and dementia.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
March 1989, The American journal of clinical nutrition,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
January 2003, Mechanisms of ageing and development,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
April 1995, Epilepsia,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
July 2003, Shock (Augusta, Ga.),
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
August 2001, Alcoholism, clinical and experimental research,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
May 2004, Immunopharmacology and immunotoxicology,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
November 1998, Vaccine,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
October 2004, Cytokine,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
August 1996, The Journal of infectious diseases,
U Fagiolo, and A Cossarizza, and E Scala, and E Fanales-Belasio, and C Ortolani, and E Cozzi, and D Monti, and C Franceschi, and R Paganelli
August 1991, Clinical and experimental immunology,
Copied contents to your clipboard!